Protocolo diagnóstico de las mielitis y otras mielopatías

  1. Alberte Woodward, M. 1
  2. Naveiro Soneira, J. 1
  3. Prieto González, J.M.Ó 1
  1. 1 Servicio de Neurología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2023

Issue Title: Enfermedades del sistema nervioso (IX): Enfermedades desmielinizantes

Series: 13

Issue: 78

Pages: 4652-4654

Type: Article

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

The initial strategy to clarify the etiology of a myelopathy is based on a combination of semiology, temporal pattern of onset and magnetic resonance findings. We may divide myelopathies into hyperacute (onset within hours, usually with a traumatic or vascular cause), acute-subacute (onset between one day and three weeks, including neoplastic, immune and infectious causes) and chronic (progression of the symptoms beyond 3 weeks, with metabolic, hereditary degenerative or structural causes such as dural fistulas and spondylosis, among others, although progressive forms of multiple sclerosis may present this temporary pattern). Spinal cord lesions in multiple sclerosis are usually short and peripheral, while in neuromyelitis optica they extend more than three vertebral segments, whereas involvement of the conus medullaris is typical in IgG-MOG disease.

Bibliographic References

  • Rovira Cañellas À, Tintoré Subirana M. Resonancia magnética en la esclerosis múltiple. En: Guía oficial de práctica clínica en esclerosis múltiple. Madrid: Luzán 5; 2014. p. 37-55.
  • Ginsberg L. Disorders of the spinal cord and roots. Pract Neurol. 2011;11(4):259-67.
  • López Chiriboga S, Flanagan EP. Myelitis and other autoimmune myelopathies. Continuum (Minneap Minn). 2021;27(1):62-92.
  • Wu J, Ranjan S. Neoplastic myelopathies. Continuum (Minneap Minn). 2018;24(2, Spinal Cord Disorders):474-96.
  • Stino AM, LoRusso SJ. Myelopathies due to structural cervical and thoracic disease. Continuum (Minneap Minn). 2018;24(2, Spi- nal Cord Disorders):567-83